Global 3D Cell Culture Market

3D Cell Culture Market Size, Share, Growth Analysis, By Products(Scaffold-Based, Scaffold-Free, Magnetic & Bioprinted and Microfluidic Organ-On-a-Chip), Application(Cancer Research, Stem Cell Research, Drug Discovery, Tissue Engineering), End User, and Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2246 | Region: Global | Published Date: July, 2024
Pages: 157 | Tables: 90 | Figures: 76

3D Cell Culture Market Insights

3D Cell Culture Market size was valued at USD 1.3 Billion in 2022 and is poised to grow from USD 1.31 Billion in 2023 to USD 11.79 Billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031). 

3D cell culture refers to the practice of growing cells outside in 3-dimensional space of the organism that they came from. This practice allows a better emulation of how cells would develop and interact in a body. High investments in cell research and development coupled with advancements in cell culture technologies will also bolster market growth in the future. Ethical concerns about animal testing are also projected to create new opportunities for 3D cell culture providers worldwide. Surging prevalence of chronic diseases and growing demand for novel treatments and therapies for the same are also estimated to benefit the 3D cell culture demand outlook over the coming years. However, limited standardization, scalability issues, and high costs are estimated to inhibit adoption of 3D cell culture in the long run. Growing demand for oncology research will also play a vital role in augmenting the global 3D cell culture market development potential through 2031 and beyond. 

US 3D Cell Culture Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

3D Cell Culture Market size was valued at USD 1.3 Billion in 2022 and is poised to grow from USD 1.31 Billion in 2023 to USD 11.79 Billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031). 

3D cell culture market players should focus on collaborations and partnerships to share their expertise and fast-track the development of novel 3D cell culture products. Developing affordable reagents and equipment required for 3D cell cultures will also offer good business scope for new entrants in the market. Investing in research will be a non-negotiable strategy for all 3D cell culture companies operating around the world. 'Thermo Fisher Scientific Inc. (US) ', 'Corning Incorporated (US) ', 'Merck KGaA (Germany) ', 'Lonza Group AG (Switzerland) ', 'Becton, Dickinson and Company (US) ', '3D Biotek LLC (US) ', 'InSphero AG (Switzerland) ', 'Synthecon Inc. (US) ', 'Tecan Trading AG (Switzerland) ', 'PromoCell GmbH (Germany) ', 'Greiner Bio-One International GmbH (Austria) ', 'Avantor, Inc. (US) ', 'Sartorius AG (Germany) ', 'Nano3D Biosciences, Inc. (US) ', 'MIMETAS B.V. (Netherlands) ', 'QGel SA (Switzerland) ', 'TissUse GmbH (Germany) ', 'SynVivo, Inc. (US) ', 'Emulate, Inc. (US) ', 'CN Bio Innovations Ltd. (UK)'

3D cell culture plays a vital role in the development of personalized medicine as it is the only way available to mimic human tissues in the most accurate way possible. Therefore, high demand for personalized medicine will also fuel market growth through 2031.  

Integration with Microfluidics: Microfluidic (organ-on-a-chip) technology has come a long way and integrating 3D cell culture with this could be the first of mankind to make artificial organs from actual human tissue. Moreover, this could also help researchers emulate and stimulate more complex conditions in organs for research purposes.

Robust spending on medical research in the North American region makes it a leader in the global 3D cell culture market. The presence of multiple pharmaceutical and biotechnology companies focusing on cell research and supportive government initiatives are helping this region maintain its dominance. Rising availability of funds to advanced 3D cell culture research and growing demand for regenerative medicine are also making the United States a top market in this region. The developed healthcare infrastructure of countries in this region also contributes to the high market share.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global 3D Cell Culture Market

Report ID: SQMIG35H2246

$5,300
BUY NOW GET FREE SAMPLE